iotechnology company specializing in new approaches for inducing cancer cell death
Jalon Therapeutics has raised €2.0M across 1 funding round, most recently a round in Dec 2022. Based in Paris, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-12-16 | Other | €2.0M |
| — |
| View deal → |
